Regulation of the human TRH (hTRH) gene by human thyroid hormone receptor beta 1 (hTR beta 1) mutants.
TRH is negatively regulated by T3 both in the hypothalamic paraventricular nucleus and transient transfection models. Mutations in hTR beta 1 genes are associated with the syndrome of generalized resistance to thyroid hormone. To investigate potential effects of mutant TRs on T3 regulation of the hTRH gene, transient gene expression assays were performed in human neuroblastoma (HTB-11) cells with an hTRH promoter-luciferase construct, wild type (WT) hTR beta 1, and three qualitatively distinct hTR beta 1 mutant forms (ED, OK and PV). In the presence of T3 (10(-9) M), liganded WT-hTR beta 1 inhibited hTRH promoter activity significantly (40%). Cotransfection of each of the two mutants (ED and OK) achieved similar levels of inhibition only at 10 to 100 fold increased T3 concentrations. Of interest, a 10x excess of mutant ED or OK could also exert dominant negative effects upon WT hTR beta 1-T3 mediated inhibitory actions on the hTRH promoter. In contrast, mutant TR-PV exerted neither inhibitory nor dominant negative effects at even higher concentrations of T3. Moreover, all three unliganded mutant forms stimulated TRH promoter activity significantly in the absence of T3, despite their different mutations in the ligand-binding domain (LBD). These data demonstrate that thyroid hormone resistance at the level of TRH gene regulation, due to reduced inhibitory actions of mutant TR-T3 complexes, as well as dominant negative effects upon WT hTR beta 1 mediated inhibition, likely contribute to elevated TSH values observed in the syndrome of thyroid hormone resistance.
Li
Q L
QL
Department of Medicine, University of Maryland School of Medicine, Baltimore 21201, USA.
Feng
P
P
Satoh
T
T
Shi
Z X
ZX
Wang
R
R
Weintraub
B D
BD
Wilber
J F
JF
D004305:Dose-Response Relationship, Drug; D005786:Gene Expression Regulation; D005796:Genes / Q000235:genetics; D006801:Humans; D008024:Ligands; D009447:Neuroblastoma; D017354:Point Mutation / Q000235:genetics / Q000502:physiology*; D011401:Promoter Regions, Genetic / Q000187:drug effects / Q000235:genetics; D011988:Receptors, Thyroid Hormone / Q000235:genetics* / Q000502:physiology; D018382:Thyroid Hormone Resistance Syndrome / Q000235:genetics / Q000503:physiopathology; D013963:Thyroid Hormones / Q000008:administration & dosage / Q000494:pharmacology; D013973:Thyrotropin-Releasing Hormone / Q000187:drug effects* / Q000235:genetics*; D014407:Tumor Cells, Cultured
D008024:Ligands; D011988:Receptors, Thyroid Hormone; D013963:Thyroid Hormones; D013973:Thyrotropin-Releasing Hormone